Authors:
DANGAS G
BADIMON JJ
COLLER BS
FALLON JT
SHARMA SK
HAYES RM
MERAJ P
AMBROSE JA
MARMUR JD
Citation: G. Dangas et al., ADMINISTRATION OF ABCIXIMAB DURING PERCUTANEOUS CORONARY INTERVENTIONREDUCES BOTH EX-VIVO PLATELET THROMBUS FORMATION AND FIBRIN DEPOSITION - IMPLICATIONS FOR A POTENTIAL ANTICOAGULANT EFFECT OF ABCIXIMAB, Arteriosclerosis, thrombosis, and vascular biology, 18(8), 1998, pp. 1342-1349
Authors:
DANGAS G
AMBROSE JA
SMITH DA
UNGER AH
FIER C
SHAO JH
MERAJ P
FALLON JT
CHESEBRO JH
BADIMON JJ
Citation: G. Dangas et al., TREATMENT OF HYPERCHOLESTEROLEMIC PATIENTS WITH AND WITHOUT CORONARY-DISEASE WITH PRAVASTATIN DECREASES THROMBUS FORMATION UNDER DYNAMIC FLOW CONDITIONS, Journal of the American College of Cardiology, 31(2), 1998, pp. 194-194
Authors:
RAUCH U
BADIMON JJ
VORCHHEIMER DA
GUZMAN I
HARRIS K
HARRIS P
SANDLER DA
FALLON JT
FUSTER V
CHESEBRO JH
Citation: U. Rauch et al., LIPID-LOWERING THERAPY REDUCES BLOOD THROMBOGENICITY IN HYPERCHOLESTEROLEMIC PATIENTS - EFFECT OF SIMVASTATIN, Journal of the American College of Cardiology, 31(2), 1998, pp. 194-194
Authors:
ALEXIS JD
FREUDENBERGER RS
KUSHWAHA SS
FUSTER V
GASS AL
BADIMON JJ
Citation: Jd. Alexis et al., ANTITHROMBOTIC EFFECT OF FK-506 VERSUS CYCLOSPORINE IN CARDIAC TRANSPLANT RECIPIENTS - POTENTIAL IMPLICATIONS IN TRANSPLANT ARTERIOPATHY, Journal of the American College of Cardiology, 31(2), 1998, pp. 207-207
Authors:
BADIMON JJ
PADUREAN A
ROQUE M
GALLO R
FALLON J
CHESEBRO JH
FUSTER V
Citation: Jj. Badimon et al., INHIBITORY EFFECTS OF RAPAMYCIN ON INTIMAL HYPERPLASIA AFTER PTCA IN THE PORCINE CORONARY MODEL - A 3-MONTH FOLLOW-UP, Journal of the American College of Cardiology, 31(2), 1998, pp. 278-278
Authors:
SHINNAR M
GALLO R
FAYAD ZA
FALLON JT
PADUREAN A
KONSTADT SN
MOSKOWITZ D
ABELA J
BADIMON JJ
FUSTER V
Citation: M. Shinnar et al., IN-VIVO MAGNETIC-RESONANCE-IMAGING OF POST-ANGIOPLASTY CORONARY VESSEL WALL LESIONS IN PIGS, Journal of the American College of Cardiology, 31(2), 1998, pp. 339-339
Citation: Jh. Chesebro et Jj. Badimon, TIROFIBAN IN UNSTABLE CORONARY-DISEASE - REPLY, The New England journal of medicine, 339(16), 1998, pp. 1165-1165
Citation: Jh. Chesebro et Jj. Badimon, PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE IN UNSTABLE CORONARY-DISEASE/, The New England journal of medicine, 338(21), 1998, pp. 1539-1541
Authors:
GERTZ SD
FALLON JT
GALLO R
TAUBMAN MB
BANAI S
BARRY WL
GIMPLE LW
NEMERSON Y
THIRUVIKRAMAN S
NAIDU SS
CHESEBRO JH
FUSTER V
SAREMBOCK IJ
BADIMON JJ
Citation: Sd. Gertz et al., HIRUDIN REDUCES TISSUE FACTOR EXPRESSION IN NEOINTIMA AFTER BALLOON INJURY IN RABBIT FEMORAL AND PORCINE CORONARY-ARTERIES, Circulation, 98(6), 1998, pp. 580-587
Authors:
VORCHHEIMER DA
RAUCH U
SANDLER DA
FUSTER V
CHESEBRO JH
ARSLAN B
GUZMAN IC
PALENCIA S
BADIMON JJ
Citation: Da. Vorchheimer et al., STATIN THERAPY REDUCES BLOOD THROMBOGENICITY - EVIDENCE FOR AN ANTITHROMBOTIC EFFECT INDEPENDENT OF LDL REDUCTION, Circulation, 98(17), 1998, pp. 2376-2376
Authors:
FAYAD ZA
FALLON JT
SHINNAR M
WEHRLI S
DANSKY HM
POON M
BADIMON JJ
CHARLTON SA
FISHER EA
BRESLOW JL
FUSTER V
Citation: Za. Fayad et al., NONINVASIVE IN-VIVO HIGH-RESOLUTION MAGNETIC-RESONANCE-IMAGING OF ATHEROSCLEROTIC LESIONS IN GENETICALLY-ENGINEERED MICE, Circulation, 98(15), 1998, pp. 1541-1547
Authors:
MEYER BJ
BADIMON JJ
CHESEBRO JH
FALLON JT
FUSTER V
BADIMON L
Citation: Bj. Meyer et al., DISSOLUTION OF MURAL THROMBUS BY SPECIFIC THROMBIN INHIBITION WITH R-HIRUDIN - COMPARISON WITH HEPARIN AND ASPIRIN, Circulation, 97(7), 1998, pp. 681-685
Authors:
GALLO R
PADUREAN A
TOSCHI V
BICHLER J
FALLON JT
CHESEBRO JH
FUSTER V
BADIMON JJ
Citation: R. Gallo et al., PROLONGED THROMBIN INHIBITION REDUCES RESTENOSIS AFTER BALLOON ANGIOPLASTY IN PORCINE CORONARY-ARTERIES, Circulation, 97(6), 1998, pp. 581-588
Authors:
DANGAS G
KING TE
DELEON J
AMBROSE JA
SHARMA SK
VIDHUN R
STOYNOV MY
BADIMON JJ
MARMUR JD
Citation: G. Dangas et al., EFFECTS OF PLATELET GPIIB IIIA INHIBITOR ON THROMBIN GENERATION AND ACTIVITY DURING PERCUTANEOUS CORONARY INTERVENTIONS/, The American journal of cardiology, 82, 1998, pp. 94-94
Authors:
VINALS M
MARTINEZGONZALEZ J
BADIMON JJ
BADIMON L
Citation: M. Vinals et al., HDL-INDUCED PROSTACYCLIN RELEASE IN SMOOTH-MUSCLE CELLS IS DEPENDENT ON CYCLOOXYGENASE-2 (COX-2), Arteriosclerosis, thrombosis, and vascular biology, 17(12), 1997, pp. 3481-3488
Authors:
PAUL SD
CAMBRIA RP
FUSTER V
GERTLER JP
KOSKI G
DAVISON KJ
BREWSTER DC
LAMURAGLIA GM
TEPLICK RS
BAMEZAI V
CAPASSO V
BADIMON JJ
ABBOTT WM
EAGLE KA
Citation: Sd. Paul et al., CIRCADIAN-RHYTHM OF POSTOPERATIVE SILENT ISCHEMIA - IMPLICATIONS FOR MANAGEMENT OF PATIENTS AFTER VASCULAR-SURGERY, Journal of the American College of Cardiology, 29(2), 1997, pp. 7615-7615
Authors:
DANGAS G
BADIMON JJ
AMBROSE JA
COLLER BS
FALLON JT
COHEN AM
MERAJ P
HAYES R
SHARMA SK
MARMUR JD
Citation: G. Dangas et al., ADDITION OF A PLATELET GLYCOPROTEIN IIB IIIA INHIBITOR TO HEPARIN PLUS ASPIRIN DECREASES EX-VIVO THROMBUS FORMATION AFTER PERCUTANEOUS CORONARY INTERVENTION/, Journal of the American College of Cardiology, 29(2), 1997, pp. 97483-97483
Authors:
BADIMON JJ
ALZUETA AF
RATAN A
RUBSAMEN K
BADIMON L
FUSTER V
CHESEBRO JH
Citation: Jj. Badimon et al., THRESHOLD INHIBITION OF THROMBUS FORMATION BY PEG-HIRUDIN, A LONGER ACTING THROMBIN INHIBITOR, Thrombosis and haemostasis, 1997, pp. 364-364
Authors:
KYRLE PA
CHESEBRO JH
FUSTER V
RUBSAMEN K
BADIMON JJ
Citation: Pa. Kyrle et al., ANTITHROMBOTIC EFFECTS OF PEG-HIRUDIN, A NEW AND LONG-LASTING THROMBIN INHIBITOR, IN HUMANS, Thrombosis and haemostasis, 1997, pp. 2006-2006
Authors:
GALLO R
BICHLER J
CHESEBRO JH
FUSTER V
BADIMON JJ
Citation: R. Gallo et al., DEEP ARTERIAL INJURY IS ASSOCIATED WITH ACUTE AND PROLONGED THROMBIN GENERATION, Thrombosis and haemostasis, 1997, pp. 2315-2315
Citation: V. Fuster et al., THE UNSTABLE ATHEROSCLEROTIC PLAQUE - CLINICAL-SIGNIFICANCE AND THERAPEUTIC INTERVENTION, Thrombosis and haemostasis, 78(1), 1997, pp. 247-255
Authors:
BADIMON JJ
MEYER B
FEIGEN LP
BARON DA
CHESEBRO JH
FUSTER V
BADIMON L
Citation: Jj. Badimon et al., THROMBOSIS TRIGGERED BY SEVERE ARTERIAL LESIONS IS INHIBITED BY ORAL-ADMINISTRATION OF A GLYCOPROTEIN IIB IIIA ANTAGONIST/, European journal of clinical investigation, 27(7), 1997, pp. 568-574